Clinical diagnosis and staging of cholangiocarcinoma
- PMID: 21808282
- PMCID: PMC3331791
- DOI: 10.1038/nrgastro.2011.131
Clinical diagnosis and staging of cholangiocarcinoma
Abstract
Cholangiocarcinoma is the most frequent biliary malignancy. It is difficult to diagnose owing to its anatomic location, growth patterns and lack of definite diagnostic criteria. Currently, cholangiocarcinoma is classified into the following types according to its anatomic location along the biliary tree: intrahepatic, perihilar or distal extrahepatic cholangiocarcinoma. These cholangiocarcinoma types differ in their biological behavior and management. The appropriate stratification of patients with regard to the anatomic location and stage of cholangiocarcinoma is a key determinate in their management. Staging systems can guide this stratification and provide prognostic information. In addition, staging systems are essential in order to compare and contrast the outcomes of different therapeutic approaches. A number of staging systems exist for cholangiocarcinoma-several early ones have been updated, and new ones are being developed. We discuss the emerging diagnostic criteria as well as the different staging systems for cholangiocarcinoma, and provide a critical appraisal regarding these advances in biliary tract malignancies.
Conflict of interest statement
Figures





Similar articles
-
Cholangiocarcinoma.Surg Pathol Clin. 2018 Jun;11(2):403-429. doi: 10.1016/j.path.2018.02.005. Surg Pathol Clin. 2018. PMID: 29751883 Review.
-
Imaging bile duct tumors: staging.Abdom Imaging. 2013 Oct;38(5):1071-81. doi: 10.1007/s00261-013-0021-9. Abdom Imaging. 2013. PMID: 23793410 Review.
-
Cholangiocarcinoma.Surg Clin North Am. 2019 Apr;99(2):315-335. doi: 10.1016/j.suc.2018.12.004. Epub 2019 Feb 10. Surg Clin North Am. 2019. PMID: 30846037 Review.
-
Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma.Cancer. 2016 May 1;122(9):1349-69. doi: 10.1002/cncr.29692. Epub 2016 Jan 22. Cancer. 2016. PMID: 26799932 Review.
-
Biliary tract cancer.Eur J Surg Oncol. 2025 Jun;51(6):108489. doi: 10.1016/j.ejso.2024.108489. Epub 2024 Jun 15. Eur J Surg Oncol. 2025. PMID: 38902180 Review.
Cited by
-
Methotrexate-loaded tumour-cell-derived microvesicles can relieve biliary obstruction in patients with extrahepatic cholangiocarcinoma.Nat Biomed Eng. 2020 Jul;4(7):743-753. doi: 10.1038/s41551-020-0583-0. Epub 2020 Jul 6. Nat Biomed Eng. 2020. PMID: 32632227
-
Anatomical Resection Improved the Outcome of Intrahepatic Cholangiocarcinoma: A Propensity Score Matching Analysis of a Retrospective Cohort.J Oncol. 2022 Oct 25;2022:4446243. doi: 10.1155/2022/4446243. eCollection 2022. J Oncol. 2022. PMID: 36330355 Free PMC article.
-
[Current Status and Recent Update of Imaging Evaluation for Peri-Hilar Cholangiocarcinoma].Taehan Yongsang Uihakhoe Chi. 2021 Mar;82(2):298-314. doi: 10.3348/jksr.2021.0018. Epub 2021 Mar 31. Taehan Yongsang Uihakhoe Chi. 2021. PMID: 36238748 Free PMC article. Review. Korean.
-
Tumor microenvironment in primary liver tumors: A challenging role of natural killer cells.World J Gastroenterol. 2020 Sep 7;26(33):4900-4918. doi: 10.3748/wjg.v26.i33.4900. World J Gastroenterol. 2020. PMID: 32952338 Free PMC article. Review.
-
The Role of Endoscopy in the Palliation of Pancreatico-Biliary Cancers: Biliary Drainage, Management of Gastrointestinal Obstruction, and Role in Relief of Oncologic Pain.Cancers (Basel). 2023 Nov 10;15(22):5367. doi: 10.3390/cancers15225367. Cancers (Basel). 2023. PMID: 38001627 Free PMC article. Review.
References
-
- Everhart JE, Ruhl CE. Burden of digestive diseases in the United States Part III: liver, biliary tract, and pancreas. Gastroenterology. 2009;136:1134–1144. - PubMed
-
- DeOliveira ML, et al. New staging system and a registry for perihilar cholangiocarcinoma. Hepatology. 2011;53:1363–1371. - PubMed
-
- Welzel TM, McGlynn KA, Hsing AW, O'Brien TR, Pfeiffer RM. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst. 2006;98:873–875. - PubMed
-
- Burak K, et al. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol. 2004;99:523–526. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical